Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Auxiliaries. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1709864A discloses a high-yield asymmetric synthesis for Taxol side chains using low-cost glycolic acid and chiral tert-butyl sulfinamide, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN101948443B details a green, one-step synthesis of 4-substituted oxazolidinones using NaBH4. This method offers significant cost reduction and high purity for pharmaceutical intermediates.
Novel non-enzymatic synthesis of niraparib intermediate via oxazolone route. High purity, scalable process offering significant cost reduction in API manufacturing.
Patent CN1144796C details a high-yield route for 2R-propyl octanoic acid intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN107488138B details a high-yield dithiolane-protected route for ezetimibe intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN1139581C details a safe, high-yield route for chiral oxazolidinones using chloroformates, offering significant cost reduction in API manufacturing and supply chain stability.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN101735118B details a silane-protected route for tert-butylsulfinamide, offering mild conditions and high purity for chiral amine synthesis.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.